The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line monotherapy with nivolumab (NIVO; anti-programmed death-1 [PD-1]) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy and correlation of outcomes with PD-1 ligand (PD-L1) expression.
 
Scott N. Gettinger
Honoraria - ARIAD; Bristol-Myers Squibb
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst)
 
Matthew David Hellmann
Consulting or Advisory Role - Third Rock Ventures
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck/Schering Plough; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Lilly
Research Funding - Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - Novartis
 
Scott Joseph Antonia
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck KGaA
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb
 
Laura Quan Man Chow
Honoraria - Astellas Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly/ImClone (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); VentiRx (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Jonathan Wade Goldman
Research Funding - ArQule; Astex Pharmaceuticals; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Lilly; Synta
 
Rosalyn A. Juergens
Honoraria - Bayer
Consulting or Advisory Role - AstraZeneca; BetaPharma; Bristol-Myers Squibb; Lilly; Merck; Novartis
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Synta (Inst)
 
Hossein Borghaei
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Lilly
Research Funding - Millennium (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Genentech; Lilly
 
Neal Ready
Consulting or Advisory Role - Bristol-Myers Squibb; Onyx
Research Funding - Bristol-Myers Squibb; Genentech
 
David E. Gerber
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Genentech (Inst)
Research Funding - ArQule (Inst); Celgene (Inst); Genentech (Inst); ImClone Systems (Inst); Immunogen (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
Travel, Accommodations, Expenses - ArQule; Lilly; Lilly
 
Faith Ellen Nathan
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Johnson & Johnson; Lilly
 
Yun Shen
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Christopher Harbison
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Naiyer A. Rizvi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Roche Pharma AG
Research Funding - Bristol-Myers Squibb